HHMI
GEV icon

Howard Hughes Medical Institute’s GE Vernova GEV Stock Holding History

Howard Hughes Medical Institute’s Portfolio GEV Stock Details GEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59
Closed -$38.6K – 497
2025
Q4 		$38.6K Hold
59
– – 0.02% 56
2025
Q3 		$36.3K Hold
59
– – 0.02% 59
2025
Q2 		$31.2K Buy
+59
New +$24.6K 0.01% 69

Other funds holding GEV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Howard Hughes Medical Institute's GEV Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of GE Vernova (GEV) in Q1 2026, closing a stake of 59 shares — an estimated $38.6K sold.

Howard Hughes Medical Institute first reported a position in GEV in Q2 2025 and held it in 3 quarters. The position peaked at $38.6K in Q4 2025. 3,124 funds tracked by Wall St. Rank hold GEV as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining GE Vernova position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 59 GE Vernova shares in Q1 2026, an estimated $38.6K.
  • Howard Hughes Medical Institute first reported a position in GE Vernova in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's GE Vernova position peaked at $38.6K in Q4 2025.
  • 3,124 funds tracked by Wall St. Rank held GE Vernova as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.